{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/385959906"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseasesUS8097621Jun 10, 2009Jan 17, 2012Pfizer Inc.Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitorsWO2002059126A1 *Dec 29, 2001Aug 1, 2002Hans-Michael EggenweilerProcess for the preparation of a pyrazolo[4,3-d]pyrimidine derivativeWO2002062343A2 *Jan 14, 2002Aug 15, 2002H" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/80830224"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/385959906" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/173238633"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/385959906"] } } }
